Bayer Alliance for Genomic Discovery Adds Major Biopharma Partners to Help Fund WGS-Based Biobank Funding from AbbVie, Amgen, AstraZeneca, Bayer, and Merck will enable DeCode Genetics to sequence an additional 215,000 samples for the alliance. Function Oncology Launches With $28M, Seeks to Transform Precision Cancer Therapy With CRISPR Premium The firm unveiled early validation data for its CRISPR-based functional genomics platform, which it hopes to commercialize as another tool doctors can use to individualize cancer care. Ginkgo Bioworks to Acquire Zymergen for $300M in Stock Separately, Ginkgo said it will acquire Bayer's West Sacramento, California R&D site for $83 million and has entered a multi-year collaboration with the firm. NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling The guidelines recognize the importance of molecular profiling in diagnosing, treating, and identifying clinical trial opportunities for children with high-grade gliomas. Illumina Adds CDx Indication to European TruSight Oncology Test for NTRK Gene Fusion Detection The CDx pan-cancer indication will allow the identification of patients with NTRK gene fusions who may benefit from therapy with Bayer's Vitrakvi (larotrectinib). May 16, 2022 Ginkgo Bioworks Q1 Revenues More Than Triple Apr 13, 2022 Precision Cancer Consortium Launches With Bayer, GSK, Roche, Novartis as Founding Members Nov 12, 2021 In Brief This Week: Caris Life Sciences, Psomagen, Tempus, CareDx, HTG Molecular, Epigenomics, More Dec 22, 2020 Bayer, Veracyte to Identify Therapy-Resistant Thyroid Cancer Patients Dec 10, 2020 Tempus Raises $200M in Series G2, Inks Oncology Testing Collaboration With Bayer Oct 26, 2020 FDA Approves Foundation Medicine CDx, Bayer's Vitrakvi for NTRK Patients May 14, 2020 ArcherDx, Bayer Partner on NGS-Based Companion Diagnostic Test Development May 5, 2020 Bayer, NeoGenomics Launch Free NTRK Fusion Testing Program Apr 30, 2020 Bayer, OrigiMed Form Companion Diagnostic Development Alliance Sep 23, 2019 Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines Premium May 29, 2019 Bayer, Foundation Medicine Partner on NGS-Based Companion Diagnostic Test Development Apr 26, 2019 European Project Aims to Develop Tools, Guidelines to Improve Data Sharing, Access Premium Apr 2, 2019 Bayer, Loxo Next-Generation TRK Inhibitor Shows Promising Activity in AACR Study Premium Nov 27, 2018 Loxo's Pan-Cancer Drug Garners FDA Approval for Patients With NTRK Fusions Oct 31, 2018 Bayer Rolling Out Portal for Translational Research Data Sharing Premium Jun 29, 2018 Bayer, Broad Institute Expand Cardiovascular Disease Research Alliance Dec 14, 2017 Ginkgo Bioworks Raises $275M to Support Foundry, Bayer Ag Venture Nov 27, 2017 European Consortium Aims to Deliver New Tests, Therapies for Cardiovascular Diseases Premium Oct 3, 2017 Ginkgo Bio Invests $10M in Transcriptic, Inks Supply Deal With Twist Bioscience Dec 21, 2016 Bayer, Leica Biosystems Collaborate on CDx for Cancer Therapies Load More Breaking News BostonGene, Johns Hopkins University Partner for Multiple Cancer Clinical Research Projects KromaTid, Noble Life Sciences Ink Distribution, OEM Agreement Promega to Develop Microsatellite Instability Companion Diagnostic Kit With GlaxoSmithKline ZeptoMetrix Quality Control Products Receive IVDR Certification Verily Awarded CDC Contract for Wastewater Surveillance The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.